
Serum Institute of India (SII) has sought from India's drug regulator approval for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said.
from IndiaTV: Google News Feed https://ift.tt/2ZMiUn4
comment 0 Comments
more_vert